Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer

Cancer Communications

Dong-Sheng Zhang¹  Yu-Hong Li¹  De-Yun Luo¹  Yan-Hong Deng²  Hui-Yan Luo³  Feng-Hua Wang⁴  Miao-Zhen Qiu⁵  Zhi-Qiang Wang⁵  Rui-Hua Xu⁵  Nong Xu⁵ 

[1] Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Medical Oncology, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, P. R. China;Department of Medical Oncology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, P. R. China;Department of Medical Oncology, West China Hospital of Sichuan University, Chengdu, P. R. China;Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, P. R. China

关键词: Colorectal cancer;    Oxaliplatin;    S-1;    Leucovorin;   

DOI  :  10.1186/s40880-015-0061-3

学科分类：肿瘤学

来源: Springer

【 授权许可】

CC BY